Health Highlights: Nov. 7, 2022
Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more
Is surgery always necessary for chronic chest pain? A new clinical trial finds patients' overall risk of death is about the same whether they choose aggressive surgical treatment or a more conservative approach focused on medication and lifestyle changes. Read more
Paxlovid might cut odds for long COVID. A new analysis showed people treated with the drug had a 26% reduced risk of developing several long COVID conditions, including heart disease, blood disorders, fatigue and other issues. Read more
Related Posts
El calentamiento del clima podría traer una bacteria necrosante a más cuerpos de agua de EE. UU.
JUEVES, 23 de marzo de 2023 (HealthDay News) -- El calentamiento global fomenta...
Bladder Trouble Worsens With Age for Women, Study Confirms
FRIDAY, Dec. 17 2021 (HealthDay News) -- A new study confirms what many older...
Insulin Isn’t the Only Blood Sugar Regulator
WEDNESDAY, Jan. 5, 2022 (HealthDay News) -- Scientists have known for 100 years...
Convertir hoteles en habitaciones para las personas sin hogar frenó la propagación de la COVID
MIÉRCOLES, 15 de diciembre de 2021 (HealthDay News) -- Una estrategia de...